Literature DB >> 3905619

Enteroadhesion fimbriae and enterotoxin of Escherichia coli: genetic transfer to a streptomycin-resistant mutant of the galE oral-route live-vaccine Salmonella typhi Ty21a.

T Yamamoto, Y Tamura, T Yokota.   

Abstract

An enterotoxigenic Escherichia coli plasmid encoding colonization factor antigen (CFA) I fimbriae and heat-stable toxin was transferred into a streptomycin-resistant mutant of the Salmonella typhi galE strain Ty21a (a live attenuated oral typhoid vaccine). The virulence plasmid-carrying transconjugants produced CFA I fimbriae and heat-stable toxin. The marked production of CFA I fimbriae was observed even in a vaccine medium for Ty21a. The data lead to a new type of potential live oral vaccine, S. typhi Ty21a producing enteroadhesion fimbriae.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3905619      PMCID： PMC261171          DOI： 10.1128/iai.50.3.925-928.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  18 in total

1.  Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen.

Authors:  D G Evans; T K Satterwhite; D J Evans; H L DuPont
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  The relationship between two apparently different enterotoxins produced by enteropathogenic strains of Escherichia coli of porcine origin.

Authors:  H W Smith; C L Gyles
Journal:  J Med Microbiol       Date:  1970-08       Impact factor: 2.472

Review 3.  Enterotoxigenic Escherichia coli: identification and characterization.

Authors:  R B Sack
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

4.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

5.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.

Authors:  R H Gilman; R B Hornick; W E Woodard; H L DuPont; M J Snyder; M M Levine; J P Libonati
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

7.  A virulence plasmid in Escherichia coli enterotoxigenic for humans: intergenetic transfer and expression.

Authors:  T Yamamoto; T Honda; T Miwatani; T Yokota
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

8.  Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor.

Authors:  D G Evans; D J Evans; W Tjoa
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

9.  New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8.

Authors:  D G Evans; D J Evans
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.

Authors:  J D Clements; S El-Morshidy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441
View more
  8 in total

Review 1.  Advances in vaccines for typhoid fever.

Authors:  A Gupta; S Jalla; S Sazawal; M K Bhan
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

2.  Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors:  C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.

Authors:  S Wu; D W Pascual; J L VanCott; J R McGhee; D R Maneval; M M Levine; D M Hone
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.

Authors:  D F Sigwart; B A Stocker; J D Clements
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4.

Authors:  C O Tacket; D R Maneval; M M Levine
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 6.  Novel antigens for enterotoxigenic Escherichia coli vaccines.

Authors:  James Fleckenstein; Alaullah Sheikh; Firdausi Qadri
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

7.  Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope; expression at the cell surface.

Authors:  A Charbit; J C Boulain; A Ryter; M Hofnung
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

8.  Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.

Authors:  M A Ascón; D M Hone; N Walters; D W Pascual
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.